Keilholz U - Search Results

1

A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer.

Schmittel A, Fischer von Weikersthal L, Sebastian M, Martus P, Schulze K, Hortig P, Reeb M, Thiel E, Keilholz U. Schmittel A, et al. Among authors: keilholz u. Ann Oncol. 2006 Apr;17(4):663-7. doi: 10.1093/annonc/mdj137. Epub 2006 Jan 19. Ann Oncol. 2006. PMID: 16423848 Free article. Clinical Trial.

2

Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effective therapy for patients with advanced multiple myeloma.

Szelényi H, Kreuser ED, Keilholz U, Menssen HD, Keitel-Wittig C, Siehl J, Knauf W, Thiel E. Szelényi H, et al. Among authors: keilholz u. Ann Oncol. 2001 Jan;12(1):105-8. doi: 10.1023/a:1008362107080. Ann Oncol. 2001. PMID: 11249035 Free article. Clinical Trial.

3

Phase I dose escalation study of carboplatin to a fixed dose of irinotecan as first-line treatment of small cell lung cancer.

Schmittel A, Schulze K, Hütter G, Krebs P, Thiel E, Keilholz U. Schmittel A, et al. Among authors: keilholz u. Onkologie. 2004 Jun;27(3):280-4. doi: 10.1159/000077979. Onkologie. 2004. PMID: 15249718 Clinical Trial.

4

A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.

Schmittel A, Schmidt-Hieber M, Martus P, Bechrakis NE, Schuster R, Siehl JM, Foerster MH, Thiel E, Keilholz U. Schmittel A, et al. Among authors: keilholz u. Ann Oncol. 2006 Dec;17(12):1826-9. doi: 10.1093/annonc/mdl309. Epub 2006 Sep 13. Ann Oncol. 2006. PMID: 16971664 Free article. Clinical Trial.

5

Phase II study of CLAD (cyclophosphamide, liposomal doxorubicin and dexamethasone) in patients with advanced multiple myeloma and historical comparison to CAD (cyclophosphamide, doxorubicin and dexamethasone).

Hütter G, Szélenyi H, Schmittel A, Siehl JM, Thiel E, Keilholz U. Hütter G, et al. Among authors: keilholz u. Hematol Oncol. 2007 Sep;25(3):132-9. doi: 10.1002/hon.821. Hematol Oncol. 2007. PMID: 17514772 Clinical Trial.

6

A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer.

Schmittel A, Sebastian M, Fischer von Weikersthal L, Martus P, Gauler TC, Kaufmann C, Hortig P, Fischer JR, Link H, Binder D, Fischer B, Caca K, Eberhardt WE, Keilholz U; Arbeitsgemeinschaft Internistische Onkologie Thoracic Oncology Study Group. Schmittel A, et al. Among authors: keilholz u. Ann Oncol. 2011 Aug;22(8):1798-804. doi: 10.1093/annonc/mdq652. Epub 2011 Jan 25. Ann Oncol. 2011. PMID: 21266516 Free article. Clinical Trial.

7

Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma.

Schmittel A, Keilholz U, Max R, Thiel E, Scheibenbogen C. Schmittel A, et al. Among authors: keilholz u. Int J Cancer. 1999 Jan 5;80(1):39-43. doi: 10.1002/(sici)1097-0215(19990105)80:1<39::aid-ijc8>3.0.co;2-y. Int J Cancer. 1999. PMID: 9935227 Free article. Clinical Trial.

8

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

Scheibenbogen C, Schmittel A, Keilholz U, Allgäuer T, Hofmann U, Max R, Thiel E, Schadendorf D. Scheibenbogen C, et al. Among authors: keilholz u. J Immunother. 2000 Mar-Apr;23(2):275-81. doi: 10.1097/00002371-200003000-00012. J Immunother. 2000. PMID: 10746554 Clinical Trial.

9

Brain metastases following interleukin-2 plus interferon-alpha-2a therapy: a follow-up study in 94 stage IV melanoma patients.

Schmittel A, Proebstle T, Engenhart-Cabillic R, Scheibenbogen C, Geueke AM, Thiel E, Keilholz U. Schmittel A, et al. Among authors: keilholz u. Eur J Cancer. 2003 Mar;39(4):476-80. doi: 10.1016/s0959-8049(02)00731-1. Eur J Cancer. 2003. PMID: 12751378

10

Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer.

Hütter G, Szélenyi H, Deckert PM, Keilholz U, Thiel E. Hütter G, et al. Among authors: keilholz u. Cancer Chemother Pharmacol. 2004 Aug;54(2):178-84. doi: 10.1007/s00280-004-0796-z. Epub 2004 Apr 28. Cancer Chemother Pharmacol. 2004. PMID: 15114411 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

415 results

Search Page